Balance Sheet

Cash Flow Statement

Acquisitions Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased

Daily Values

Growth Metrics

Fulgent Genetics (FLGT) Shares Issued (2017 - 2026)

Fulgent Genetics' Shares Issued history spans 7 years, with the latest figure at $9000.0 for Q1 2026.

On a quarterly basis, Shares Issued changed N/A to $9000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $9000.0, a 25.0% decrease, with the full-year FY2025 number at $1000.0, down 98.04% from a year prior.
Shares Issued hit $9000.0 in Q1 2026 for Fulgent Genetics, down from $12000.0 in the prior quarter.
Over the last five years, Shares Issued for FLGT hit a ceiling of $16000.0 in Q1 2022 and a floor of $3000.0 in Q2 2022.